Investigation on Metabolism of Cisplatin Resistant Ovarian Cancer Using a Genome Scale Metabolic Model and Microarray Data

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2015 May 7

PMID 25945240

Citations 15

Authors

Ehsan Motamedian

Ghazaleh Ghavami

Soroush Sardari

Affiliations

Soon will be listed here.

Abstract

Objectives: Many cancer cells show significant resistance to drugs that kill drug sensitive cancer cells and non-tumor cells and such resistance might be a consequence of the difference in metabolism. Therefore, studying the metabolism of drug resistant cancer cells and comparison with drug sensitive and normal cell lines is the objective of this research.

Material And Methods: Metabolism of cisplatin resistant and sensitive A2780 epithelial ovarian cancer cells and normal ovarian epithelium has been studied using a generic human genome-scale metabolic model and transcription data.

Result: The results demonstrate that the most different metabolisms belong to resistant and normal models, and the different reactions are involved in various metabolic pathways. However, large portion of distinct reactions are related to extracellular transport for three cell lines. Capability of metabolic models to secrete lactate was investigated to find the origin of Warburg effect. Computational results introduced SLC25A10 gene, which encodes mitochondrial dicarboxylate transporter involved in exchanging of small metabolites across the mitochondrial membrane that may play key role in high growing capacity of sensitive and resistant cancer cells. The metabolic models were also used to find single and combinatorial targets that reduce the cancer cells growth. Effect of proposed target genes on growth and oxidative phosphorylation of normal cells were determined to estimate drug side-effects.

Conclusion: The deletion results showed that although the cisplatin did not cause resistant cancer cells death, but it shifts the cancer cells to a more vulnerable metabolism.

Citing Articles

Constraint-based modelling predicts metabolic signatures of low and high-grade serous ovarian cancer.

Meeson K, Schwartz J NPJ Syst Biol Appl. 2024; 10(1):96.

PMID: 39181893 PMC: 11344801. DOI: 10.1038/s41540-024-00418-5.

Targeting metabolic fluxes reverts metastatic transitions in ovarian cancer.

Arora G, Banerjee M, Langthasa J, Bhat R, Chatterjee S iScience. 2023; 26(11):108081.

PMID: 37876796 PMC: 10590820. DOI: 10.1016/j.isci.2023.108081.

The role of PYCR1 in inhibiting 5-fluorouracil-induced ferroptosis and apoptosis through SLC25A10 in colorectal cancer.

Zhou B, Mai Z, Ye Y, Song Y, Zhang M, Yang X Hum Cell. 2022; 35(6):1900-1911.

PMID: 36104652 DOI: 10.1007/s13577-022-00775-5.

MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44.

Liu X, Zhao T, Yuan Z, Ge S Cell Death Discov. 2022; 8(1):216.

PMID: 35443748 PMC: 9021257. DOI: 10.1038/s41420-022-01000-w.

Reconstruction of a generic genome-scale metabolic network for chicken: Investigating network connectivity and finding potential biomarkers.

Salehabadi E, Motamedian E, Shojaosadati S PLoS One. 2022; 17(3):e0254270.

PMID: 35316277 PMC: 8939822. DOI: 10.1371/journal.pone.0254270.

References

Jones N, Schulze A . Targeting cancer metabolism--aiming at a tumour's sweet-spot. Drug Discov Today. 2011; 17(5-6):232-41. DOI: 10.1016/j.drudis.2011.12.017. View

Echtay K, Roussel D, St-Pierre J, Jekabsons M, Cadenas S, Stuart J . Superoxide activates mitochondrial uncoupling proteins. Nature. 2002; 415(6867):96-9. DOI: 10.1038/415096a. View

Mirandola S, Melo D, Schuck P, Ferreira G, Wajner M, Castilho R . Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis. 2008; 31(1):44-54. DOI: 10.1007/s10545-007-0798-1. View

Toyoshima S, Watanabe F, Saido H, Miyatake K, Nakano Y . Methylmalonic acid inhibits respiration in rat liver mitochondria. J Nutr. 1995; 125(11):2846-50. DOI: 10.1093/jn/125.11.2846. View

Li M, Balch C, Montgomery J, Jeong M, Chung J, Yan P . Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics. 2009; 2:34. PMC: 2712480. DOI: 10.1186/1755-8794-2-34. View

Wang Y, Eddy J, Price N . Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE. BMC Syst Biol. 2012; 6:153. PMC: 3576361. DOI: 10.1186/1752-0509-6-153. View

DeBerardinis R, Lum J, Hatzivassiliou G, Thompson C . The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008; 7(1):11-20. DOI: 10.1016/j.cmet.2007.10.002. View

Jensen P, Papin J . Functional integration of a metabolic network model and expression data without arbitrary thresholding. Bioinformatics. 2010; 27(4):541-7. PMC: 6276961. DOI: 10.1093/bioinformatics/btq702. View

Blazier A, Papin J . Integration of expression data in genome-scale metabolic network reconstructions. Front Physiol. 2012; 3:299. PMC: 3429070. DOI: 10.3389/fphys.2012.00299. View

10.

Ralph S, Rodriguez-Enriquez S, Neuzil J, Moreno-Sanchez R . Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger. Mol Aspects Med. 2009; 31(1):29-59. DOI: 10.1016/j.mam.2009.12.006. View

11.

Colijn C, Brandes A, Zucker J, Lun D, Weiner B, Farhat M . Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLoS Comput Biol. 2009; 5(8):e1000489. PMC: 2726785. DOI: 10.1371/journal.pcbi.1000489. View

12.

Agarwal R, Kaye S . Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer. 2003; 3(7):502-16. DOI: 10.1038/nrc1123. View

13.

Koga Y, Yoshino M, Yamashita F . Effects of short and medium chain length fatty acids on pyruvate oxidation by cultured human fibroblasts and rat liver mitochondria. J Inherit Metab Dis. 1984; 7(3):141-2. DOI: 10.1007/BF01801777. View

14.

Duarte N, Becker S, Jamshidi N, Thiele I, Mo M, Vo T . Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A. 2007; 104(6):1777-82. PMC: 1794290. DOI: 10.1073/pnas.0610772104. View

15.

Gogvadze V, Zhivotovsky B, Orrenius S . The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med. 2009; 31(1):60-74. DOI: 10.1016/j.mam.2009.12.004. View

16.

Thiele I, Swainston N, Fleming R, Hoppe A, Sahoo S, Aurich M . A community-driven global reconstruction of human metabolism. Nat Biotechnol. 2013; 31(5):419-25. PMC: 3856361. DOI: 10.1038/nbt.2488. View

17.

Becker S, Palsson B . Context-specific metabolic networks are consistent with experiments. PLoS Comput Biol. 2008; 4(5):e1000082. PMC: 2366062. DOI: 10.1371/journal.pcbi.1000082. View

18.

Bordbar A, Palsson B . Using the reconstructed genome-scale human metabolic network to study physiology and pathology. J Intern Med. 2011; 271(2):131-41. PMC: 3243107. DOI: 10.1111/j.1365-2796.2011.02494.x. View

19.

Amani Shalamzari S, Agha-Alinejad H, Alizadeh S, Shahbazi S, Kashani Khatib Z, Kazemi A . The effect of exercise training on the level of tissue IL-6 and vascular endothelial growth factor in breast cancer bearing mice. Iran J Basic Med Sci. 2014; 17(4):231-58. PMC: 4046231. View

20.

Schellenberger J, Que R, Fleming R, Thiele I, Orth J, Feist A . Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat Protoc. 2011; 6(9):1290-307. PMC: 3319681. DOI: 10.1038/nprot.2011.308. View